The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Avelumab (MSB0010718C; anti-PD-L1) in patients with advanced cancer: safety data from 1300 patients enrolled in the phase 1b JAVELIN Solid Tumor trial.
 
Karen Kelly
Honoraria - Bristol-Myers Squibb; Roche
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Lilly; Synta
Research Funding - Abbvie (Inst); Celgene (Inst); EMD Serono (Inst); Genentech (Inst); Gilead Sciences (Inst); Lilly (Inst); Millennium (Inst); Novartis (Inst); Synta (Inst)
Patents, Royalties, Other Intellectual Property - Author Royalties for UpToDate, an evidence based, peer reviewed information resource, available via the web, desktop, and PDA.
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Clovis Oncology; Lilly; Roche; Synta
 
Christopher Ryan Heery
No Relationships to Disclose
 
Manish R. Patel
No Relationships to Disclose
 
Jeffrey R. Infante
Consulting or Advisory Role - EMD Serono
Research Funding - EMD Serono (Inst)
 
Nicholas Iannotti
No Relationships to Disclose
 
Joseph W. Leach
Employment - Minnesota Oncology
Research Funding - AstraZeneca (Inst); Clovis Oncology (Inst); EMD Serono (Inst); Genentech (Inst)
 
Ding Wang
No Relationships to Disclose
 
Jason Claud Chandler
Consulting or Advisory Role - Alexion Pharmaceuticals; Bristol-Myers Squibb; Onyx
Travel, Accommodations, Expenses - Caris MPI
 
Hendrik-Tobias Arkenau
No Relationships to Disclose
 
Matthew H. Taylor
Consulting or Advisory Role - Eisai; Onyx; PDX Pharmacy
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celldex (Inst); Eisai (Inst); Merck KGaA (Inst); Novartis (Inst)
 
Michael S. Gordon
Stock and Other Ownership Interests - Caremission; Medelis
Research Funding - Abbvie (Inst); Amgen (Inst); Array BioPharma (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Lilly (Inst); Lilly/ImClone (Inst); MedImmune (Inst); Merck Serono (Inst); Millennium (Inst); OncoMed (Inst); Pfizer (Inst); Sirtex Medical (Inst)
 
Deborah Jean Lee Wong
Research Funding - BioMed Valley Discoveries (Inst); EMD Serono (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Merck
 
Howard Safran
No Relationships to Disclose
 
Howard Kaufman
Honoraria - Alkermes; Amgen; EMD Serono; Merck; Prometheus; Sanofi Pasteur
Consulting or Advisory Role - Alkermes; Amgen; Merck; Merck Serono; Prometheus
Speakers' Bureau - Merck
Research Funding - Bristol-Myers Squibb/Medarex
Travel, Accommodations, Expenses - Alkermes; EMD Serono; Sanofi
 
Ulrich Keilholz
Honoraria - Novartis
Consulting or Advisory Role - Boehringer Ingelheim; Lilly; MSD
Travel, Accommodations, Expenses - Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Pfizer
 
Marcis Bajars
Employment - EMD Serono
 
Anja von Heydebreck
Employment - Merck KGaA
Stock and Other Ownership Interests - Merck KGaA
 
Isabell Speit
Employment - Merck KGaA
 
Jean-Marie Cuillerot
Employment - EMD Serono
 
James L. Gulley
Consulting or Advisory Role - Prime Oncology; TRM Oncology
Travel, Accommodations, Expenses - Prime Oncology; TRM Oncology